Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Jun 30, 2018

Filed with the SEC on Aug 13, 2018 and accepted by EDGAR at Aug 13, 2018, 20:05 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2018-04-01 to 2018-06-30$225.5kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2018-01-01 to 2018-06-30$330.6kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2018-04-01 to 2018-06-30−$1.2mus-gaap:OperatingIncomeLoss
Operating income6 months2018-01-01 to 2018-06-30−$2.3mus-gaap:OperatingIncomeLoss
Net income3 months2018-04-01 to 2018-06-30−$1.3mus-gaap:NetIncomeLoss
Net income6 months2018-01-01 to 2018-06-30−$2.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2018-04-01 to 2018-06-30−$0.16us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2018-01-01 to 2018-06-30−$0.33us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2018-01-01 to 2018-06-30−$1.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Current assetsAt period end2018-06-30$23.2kus-gaap:AssetsCurrent
Total assetsAt period end2018-06-30$229.7kus-gaap:Assets
Current liabilitiesAt period end2018-06-30$3.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-06-30$7.5mus-gaap:Liabilities
Shareholders' equityAt period end2018-06-30−$7.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-18-010817. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.